Violence prevalence and prevention status in China.


Journal

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention
ISSN: 1475-5785
Titre abrégé: Inj Prev
Pays: England
ID NLM: 9510056

Informations de publication

Date de publication:
02 2019
Historique:
received: 28 11 2017
revised: 16 08 2018
accepted: 05 12 2018
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 31 8 2019
Statut: ppublish

Résumé

To describe the prevalence status of violence and its prevention in China, and to provide reference for the development of strategies regarding violence prevention. Violence mortality data between 2006 and 2015 were obtained from the national disease/death surveillance data set in 2006-2015. Data on violence-related medical cases were collected from the 2015 National Injury Surveillance System. The laws and policies about violence prevention and violence prevention programmes in China were described. Violence mortality declined by 57.02% during 2006-2015 from 1.21/100 000 to 0.52/100 000. Violent death rate in males peaked in the age group 25-29 years (1.05/100 000) and it was low in the age group <15 years. Female violence mortality rate peaked during infancy (0.54/100 000), aged 25-29 (0.53/100 000) and age above 85 (0.98/100 000). The laws and policies about violence prevention were more perfect, while most prevention programmes were limited in scale and duration. The mortality of violence declined in China during 2006-2015. It is necessary to conduct gender-specific prevention strategies and improve the data collection and prevention service.

Identifiants

pubmed: 30670561
pii: injuryprev-2017-042593
doi: 10.1136/injuryprev-2017-042593
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-73

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Xin Gao (X)

Division of Injury Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Pengpeng Ye (P)

Division of Injury Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Yuliang Er (Y)

Division of Injury Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Ye Jin (Y)

Division of Injury Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Linhong Wang (L)

Division of Injury Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Leilei Duan (L)

Division of Injury Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China duanleilei@ncncd.chinacdc.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH